| Volume: | 3,220,929 |
|---|---|
| Day's Low: | $51.55 |
| 52-wk Low: | $36.90 |
| Previous Close: | $51.83 |
| Dividend: | $0.00 |
| Market Cap: | 24,381,900 |
| Avg Volume: | 3,357,900 |
|---|---|
| Day's High: | $53.26 |
| 52-wk High: | $63.09 |
| Open Price: | $51.67 |
| Yield: | 0.00% |
| P/E (Forward): | 28.68 |
| 10:29 AM | 10/22/2009 | UPDATE: Celgene 3Q Beats Views; Raises 2009 Estimates |
| 8:53 AM | 10/22/2009 | UPDATE: BEFORE THE BELL -2: US HOT STOCKS TO WATCH |
| 8:22 AM | 10/22/2009 | Celgene 3Q Net Up 58%, Beats Views |
| 2:40 PM | 10/16/2009 | US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches |
| 10/27/2009 | Celgene (CELG): Bet on biotech for 'offense and defense' |
| 10/22/2009 | Updates, advisories and surprises |
| 10/21/2009 | Stocks in focus for Thursday |
| 9/21/2009 | Monday's biggest gaining and declining stocks |
| 8/31/2009 | Biotechs Not Showing Much Life |
| 7/27/2009 | Better Near-Term Biotech Picks |
| 7/25/2009 | Charting The Market |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.50 | 0.34 | 47.06 |
| EPS, GAAP | 0.46 | 0.29 | 58.62 |
| Consensus Estimate | 0.49 | 0.35 | 40.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.60 | 1.41 | 13.48 |
| EPS, GAAP | 0.83 | -3.25 | NA |
| Consensus Estimate | 1.68 | NA | NA |
| CELG | Industry Average | |
| P/E (TTM) | 63.92 | 185.00 |
| P/E (Forward) | 28.68 | -21.30 |
| PEG Ratio | 1.18 | -1.08 |
| Price/Sales | 9.69 | 4.67 |
| Beta | 0.45 | 0.42 |